Bibliographic Details
| Title: |
Molecular characterization of selectively vulnerable neurons in Alzheimer's disease. |
| Authors: |
Leng, Kun (AUTHOR), Li, Emmy (AUTHOR), Eser, Rana (AUTHOR), Piergies, Antonia (AUTHOR), Sit, Rene (AUTHOR), Tan, Michelle (AUTHOR), Neff, Norma (AUTHOR), Li, Song Hua (AUTHOR), Rodriguez, Roberta Diehl (AUTHOR), Suemoto, Claudia Kimie (AUTHOR), Leite, Renata Elaine Paraizo (AUTHOR), Ehrenberg, Alexander J. (AUTHOR), Pasqualucci, Carlos A. (AUTHOR), Seeley, William W. (AUTHOR), Spina, Salvatore (AUTHOR), Heinsen, Helmut (AUTHOR), Grinberg, Lea T. (AUTHOR), Kampmann, Martin (AUTHOR) |
| Source: |
Nature Neuroscience. 2021, Vol. 24 Issue 2, p276-287. 12p. |
| Abstract: |
Alzheimer's disease (AD) is characterized by the selective vulnerability of specific neuronal populations, the molecular signatures of which are largely unknown. To identify and characterize selectively vulnerable neuronal populations, we used single-nucleus RNA sequencing to profile the caudal entorhinal cortex and the superior frontal gyrus—brain regions where neurofibrillary inclusions and neuronal loss occur early and late in AD, respectively—from postmortem brains spanning the progression of AD-type tau neurofibrillary pathology. We identified RORB as a marker of selectively vulnerable excitatory neurons in the entorhinal cortex and subsequently validated their depletion and selective susceptibility to neurofibrillary inclusions during disease progression using quantitative neuropathological methods. We also discovered an astrocyte subpopulation, likely representing reactive astrocytes, characterized by decreased expression of genes involved in homeostatic functions. Our characterization of selectively vulnerable neurons in AD paves the way for future mechanistic studies of selective vulnerability and potential therapeutic strategies for enhancing neuronal resilience. Leng et al. uncover the molecular signature of neuronal subpopulations that are selectively vulnerable to tau aggregation and death early in Alzheimer's disease in the human entorhinal cortex and other brain regions, validating RORB as a marker. [ABSTRACT FROM AUTHOR] |
|
Copyright of Nature Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Psychology and Behavioral Sciences Collection |
